Related references
Note: Only part of the references are listed.Syndecan-1 and-4 influence Wnt signaling and cell migration in human breast cancers
Son H. Pham et al.
BIOCHIMIE (2022)
Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer
Jessica Oyie Sousa Onyeisi et al.
BIOMOLECULES (2021)
Characterization of Krt19(CreERT) allele for targeting the nucleus pulposus cells in the postnatal mouse intervertebral disc
Sarthak Mohanty et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Culturedex vivo
Xuan Huang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Syndecan-1 could be added to hormonal receptors and HER2/neu in routine assessment of invasive breast carcinoma, relation of its expression to prognosis and clinicopathological parameters
Nahed A. Soliman et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors
Pooja Sharma et al.
SCIENTIFIC REPORTS (2019)
Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis
Raphael Leblanc et al.
Oncotarget (2018)
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
Arvindhan Nagarajan et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program population-based study
Atanu Bhattacharjee et al.
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2018)
The role of heparins and nano-heparins as therapeutic tool in breast cancer
Nikos A. Afratis et al.
GLYCOCONJUGATE JOURNAL (2017)
Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway
Shuang Shi et al.
ONCOTARGET (2017)
Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer
Xiangrong Cui et al.
ONCOTARGET (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score
Marine Jary et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway
Tomoaki Ohtsuka et al.
SCIENTIFIC REPORTS (2016)
Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma
Ghazal Heidari-Hamedani et al.
CELLULAR SIGNALLING (2015)
Determinants of Glycosaminoglycan (GAG) Structure
Kristian Prydz
BIOMOLECULES (2015)
Heparan Sulfate Proteoglycans and Human Breast Cancer Epithelial Cell Tumorigenicity
Rachel K. Okolicsanyi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma
Imge Kunter et al.
ONCOLOGY REPORTS (2014)
Syndecan-1 Overexpression Is Associated With Nonluminal Subtypes and Poor Prognosis in Advanced Breast Cancer
Thuy L. Nguyen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells
Christina J. Malavaki et al.
FEBS JOURNAL (2013)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Significance of Heparanase in Cancer and Inflammation
Israel Vlodavsky et al.
CANCER MICROENVIRONMENT (2012)
Syndecan-1 in Breast Cancer Stroma Fibroblasts Regulates Extracellular Matrix Fiber Organization and Carcinoma Cell Motility
Ning Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
Sherene Loi et al.
CURRENT OPINION IN ONCOLOGY (2011)
Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma
Maria E. Lendorf et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Heparan Sulfate Proteoglycans
Stephane Sarrazin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans
Catherine Kirn-Safran et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Rethinking TNM: Breast cancer TNM classification for treatment decision-making and research
U Veronesi et al.
BREAST (2006)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by glypican-4 expression
A Karihaloo et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Prognostic value of proliferation in invasive breast cancer: a review
PJ van Diest et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Functions of heparan sulfate proteoglycans in cell signaling during development
XH Lin
DEVELOPMENT (2004)